Mizuho analyst Vijay Rakesh maintains NXP Semiconductors (NASDAQ:NXPI) with a Neutral and lowers the price target from $205 to $200.
Where Xenon Pharmaceuticals Stands With Analysts
Analysts have provided the following ratings for Xenon Pharmaceuticals (NASDAQ:XENE) within the last quarter: Bullish Somewhat Bullish Indifferent…